Cho Byung-Rae, Jang Dong-Kyu, Jang Kyung-Sool, Moon Byung-Hoo, Cho Hyunji
Department of Neurosurgery, Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Incheon, Republic of Korea.
Department of Neurology, Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Incheon, Republic of Korea.
Int J Neurosci. 2023 Dec;133(11):1271-1284. doi: 10.1080/00207454.2022.2078206. Epub 2022 May 26.
To evaluate predictors for intracerebral hemorrhage (ICH) and 1-month mortality after intravenous (IV) or intraarterial (IA) recanalization therapy for major cerebral artery occlusion in Korean patients.
From 2011 to 2015, we prospectively gathered data from consecutive patients treated with IV/IA recanalization within 8 h of symptoms in a single center. The effects of demographic, clinical, laboratory, and radiological factors on ICH within 2 weeks were assessed, as well as 1-month mortality.
From a total of 183 patients, symptomatic intracerebral hemorrhage (SICH) occurred in 32 patients (17.5%), and asymptomatic ICH occurred in 37 patients (20.2%). The mortality rate at 1 month in ICH patients was 37.7%. The international normalized ratio (INR) (OR, 4.9; 95% CI, 1.03-23.4; = 0.046), glucose (OR, 1.119 per mmol/L; 95% CI, 1.015-1.233; = 0.023), medium-volume infarct (15-69.9 mL) (OR, 2.62; 95% CI, 1.1-6.26; = 0.03), large-volume infarct (≥70 mL) (OR, 5.54; 95% CI, 2.1-14.6; = 0.001), and angioplasty or stenting (OR, 6.29; 95% CI, 1.71-23.22; = 0.006) were predictors of any ICH. Hyperlipidemia or statin medication (OR, 4.17; 95% CI, 1.38-12.59; = 0.011), INR (OR, 7.13; 95% CI, 0.94-54.22 = 0.058), and large-volume infarct (≥70 mL) (OR, 7.96; 95% CI, 2.31-27.39; = 0.001) were predictors of SICH. Hypertension (OR, 5.77; 95% CI, 1.43-23.3; = 0.014), initial NIHSS score (OR, 1.09; 95% CI, 1.01-1.18; = 0.27), and SICH (OR, 15.7; 95% CI, 4.04-61.08; < 0.001) were predictors of 1-month mortality.
INR and glucose may be strong modifiable predictors of critical ICH leading to death after IV/IA recanalization therapy in acute cerebral artery occlusion.
评估韩国患者大脑中动脉闭塞静脉(IV)或动脉内(IA)再通治疗后脑出血(ICH)及1个月死亡率的预测因素。
2011年至2015年,我们前瞻性收集了在单一中心症状出现8小时内接受IV/IA再通治疗的连续患者的数据。评估了人口统计学、临床、实验室和放射学因素对2周内ICH以及1个月死亡率的影响。
在总共183例患者中,32例(17.5%)发生有症状脑出血(SICH),37例(20.2%)发生无症状ICH。ICH患者1个月时的死亡率为37.7%。国际标准化比值(INR)(比值比[OR],4.9;95%置信区间[CI],1.03 - 23.4;P = 0.046)、血糖(OR,每毫摩尔/升1.119;95% CI,1.015 - 1.233;P = 0.023)、中等体积梗死(15 - 69.9毫升)(OR,2.62;95% CI,1.1 - 6.26;P = 0.03)、大体积梗死(≥70毫升)(OR,5.54;95% CI,2.1 - 14.6;P = 0.001)以及血管成形术或支架置入(OR,6.29;95% CI,1.71 - 23.22;P = 0.006)是任何ICH的预测因素。高脂血症或他汀类药物治疗(OR,4.17;95% CI,1.38 - 12.59;P = 0.011)、INR(OR,7.13;95% CI,0.94 - 54.22;P = 0.058)以及大体积梗死(≥70毫升)(OR,7.96;95% CI,2.31 - 27.39;P = 0.001)是SICH的预测因素。高血压(OR,5.77;95% CI,1.43 - 23.3;P = 0.014)、初始美国国立卫生研究院卒中量表(NIHSS)评分(OR,1.09;95% CI,1.01 - 1.18;P = 0.27)以及SICH(OR,15.7;95% CI,4.04 - 61.08;P < 0.001)是1个月死亡率的预测因素。
INR和血糖可能是急性脑动脉闭塞IV/IA再通治疗后导致死亡的严重ICH的强有力的可改变预测因素。